Showing results (1211-1220 of 1,353) with videos related to

Sort By:
Pageof 136
Vox Sanguinis|May 13, 2022
Autologous red blood cell transfusion does not result in a more profound increase in pulmonary capillary wedge pressure compared to saline in critically ill patients: A randomized crossover trialJoachim J Bosboom, Robert B Klanderman, Lotte E Terwindt, et al.
Heliyon|July 8, 2024
Real-life treatment persistence and treatment outcomes of Finnish patients with inflammatory bowel disease receiving vedolizumab as first-line biological treatmentTero Ylisaukko-Oja, Clas-Göran Af Björkesten, Anja Eberl, et al.
Basic Research in Cardiology|June 30, 2026
Peroxisomal catalase and plasmalogen biosynthesis protect from oxidative stress in Barth syndrome cardiomyopathyElsie Kajese, Malte Hachmann, Katharina J Ermer, et al.
Therapeutic Advances in Hematology|December 2, 2024
Efficacy of emicizumab in patients with severe haemophilia A without factor VIII inhibitors in Germany: evaluation of real-life data documented by the smart medication eDiaryCarmen Escuriola Ettingshausen, Wolfgang Eberl, Hermann Eichler, et al.
Brain, Behavior, and Immunity|July 12, 2023
Delayed cognitive impairments in a rat model of Gulf War Illness are stimulus-dependentH E Burzynski, K E Ayala, M A Frick, et al.
Hamostaseologie|November 8, 2011
Inhibitor-immunology-study. Evaluation of inhibitor development in haemophilia BI Wieland, C Wermes, B Eifrig, et al.
The Journal of Infectious Diseases|April 4, 2017
The Antigen-Presenting Potential of Vγ9Vδ2 T Cells During Plasmodium falciparum Blood-Stage InfectionJennifer Howard, Séverine Loizon, Christopher J Tyler, et al.
Journal of Medical Virology|September 15, 2007
Fifteen years of env C2V3C3 evolution in six individuals infected clonally with human immunodeficiency virus type 1Bernd Kupfer, Tobias Sing, Peter Schüffler, et al.
Nature Communications|September 18, 2023
Ecophysiology and interactions of a taurine-respiring bacterium in the mouse gutHuimin Ye, Sabrina Borusak, Claudia Eberl, et al.
Cell Reports|May 4, 2022
Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic diseaseKenneth G Trieu, Shih-Ying Tsai, Markus Eberl, et al.
Pageof 136